Search tips
Search criteria 


Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
J Clin Invest. 1972 May; 51(5): 1287–1291.
PMCID: PMC292260

Biologic effects of 1,25-dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic rats


The development of a vitamin D-resistant state in the course of renal failure may be responsible for reduced intestinal absorption of calcium and an impaired response of skeletal tissue. Moreover, the kidney has been shown to carry out the conversion of 25-hydroxycholecalciferol (25-OH-CC) to a highly biologically active metabolite, 1,25-dihydroxycholecalciferol (1,25-diOH-CC). In the present studies, vitamin D-deficient rats, made acutely uremic by either bilateral nephrectomy or urethral ligation, received physiological doses of cholecalciferol (vitamin D3) (CC), 25-OH-CC or 1,25-diOH-CC; 24 hr later intestinal calcium transport, in vitro, and bone calcium mobilization, in vivo, were assessed. Whereas CC and 25-OH-CC stimulated calcium transport in sham-operated controls, they were without effect in the uremic animals. In contrast, administration of 1,25-diOH-CC stimulated calcium transport in both groups of uremic animals. Administration of 1,25-diOH-CC also stimulated calcium mobilization from bone in each group of animals. However, CC and 25-OH-CC were only effective in the sham controls and the uremic group produced by urethral ligation and had little or no effect in animals without kidneys. These results indicate that renal conversion of calciferol to a more biologically active form is necessary for the stimulation of intestinal calcium absorption and calcium mobilization from bone, and that 1,25-diOH-CC may bypass a possible defect in vitamin D metabolism in uremia. From these studies it is likely that uremia, per se, may also impair intestinal calcium transport.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (727K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Baerg RD, Kimberg DV, Gershon E. Effect of renal insufficiency on the active transport of calcium by the small intestine. J Clin Invest. 1970 Jun;49(6):1288–1300. [PMC free article] [PubMed]
  • Avioli LV, Birge S, Lee SW, Slatopolsky E. The metabolic fate of vitamin D3-3H in chronic renal failure. J Clin Invest. 1968 Oct;47(10):2239–2252. [PMC free article] [PubMed]
  • Ponchon G, Kennan AL, DeLuca HF. "Activation" of vitamin D by the liver. J Clin Invest. 1969 Nov;48(11):2032–2037. [PMC free article] [PubMed]
  • Myrtle JF, Haussler MR, Norman AW. Evidence for the biologically active form of cholecalciferol in the intestine. J Biol Chem. 1970 Mar 10;245(5):1190–1196. [PubMed]
  • Lawson DE, Wilson PW, Kodicek E. Metabolism of vitamin D. A new cholecalciferol metabolite, involving loss of hydrogen at C-1, in chick intestinal nuclei. Biochem J. 1969 Nov;115(2):269–277. [PubMed]
  • Lawson DE, Fraser DR, Kodicek E, Morris HR, Williams DH. Identification of 1,25-dihydroxycholecalciferol, a new kidney hormone controlling calcium metabolism. Nature. 1971 Mar 26;230(5291):228–230. [PubMed]
  • Holick MF, Schnoes HK, DeLuca HF. Identification of 1,25-dihydroxycholecalciferol, a form of vitamin D3 metabolically active in the intestine. Proc Natl Acad Sci U S A. 1971 Apr;68(4):803–804. [PubMed]
  • Fraser DR, Kodicek E. Unique biosynthesis by kidney of a biological active vitamin D metabolite. Nature. 1970 Nov 21;228(5273):764–766. [PubMed]
  • Norman AW, Midgett RJ, Myrtle JF, Nowicki HG. Studies on calciferol metabolism. I. Production of vitamin D metabolite 4B from 25-OH-cholecalciferol by kidney homogenates. Biochem Biophys Res Commun. 1971 Mar 19;42(6):1082–1087. [PubMed]
  • Gray R, Boyle I, DeLuca HF. Vitamin D metabolism: the role of kidney tissue. Science. 1971 Jun 18;172(3989):1232–1234. [PubMed]
  • DE LUCA HF, GUROFF G, STEENBOCK H, REISER S, MANNATT MR. Effect of various vitamin deficiencies on citric acid metabolism in the rat. J Nutr. 1961 Oct;75:175–180. [PubMed]
  • Adams TH, Norman AW. Studies on the mechanism of action of calciferol. I. Basic parameters of vitamin D-mediated calcium transport. J Biol Chem. 1970 Sep 10;245(17):4421–4431. [PubMed]
  • Siest G, Vigneron C. Etude du dosage de l'urée et de la citrulline en milieu protéique. Méthode manuelle et automatique à la diacetylmonoxime. Clin Chim Acta. 1968;20(3):373–379. [PubMed]
  • Hill LF, Van den Berg CJ, Mawer EB. Vitamin D metabolism in experimental uraemia: effects on intestinal transport 45 Ca and on formation of 1,25-dihydroxycholecalciferol in rat. Nat New Biol. 1971 Aug 11;232(2):189–191. [PubMed]
  • Weber JC, Pons V, Kodicek E. The localization of 1,25-dihydroxycholecalciferol in bone cell nuclei of rachitic chicks. Biochem J. 1971 Nov;125(1):147–153. [PubMed]
  • Harrison HE. Parathyroid hormone and vitamin D. Yale J Biol Med. 1966 Apr;38(5):393–409. [PMC free article] [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation